Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.

Kridin, Khalaf; Schonmann, Yochai; Damiani, Giovanni; Peretz, Avi; Onn, Erez; Bitan, Dana Tzur; Cohen, Arnon D

Kridin, Khalaf; Schonmann, Yochai; Damiani, Giovanni; Peretz, Avi; Onn, Erez; Bitan, Dana Tzur; Cohen, Arnon D.

Afiliación

Kridin K; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Schonmann Y; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Damiani G; Clalit Health Services, Tel-Aviv, Israel.
Peretz A; Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Onn E; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Bitan DT; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Cohen AD; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Dermatol Ther ; 34(4): e15003, 2021 07.

Article en En | MEDLINE | ID: mdl-34033207

Asunto(s)

Antirreumáticos; COVID-19; Psoriasis; Antirreumáticos/uso terapéutico; Estudios de Cohortes; Hospitalización; Humanos; Psoriasis/diagnóstico; Psoriasis/tratamiento farmacológico; Psoriasis/epidemiología; SARS-CoV-2; Inhibidores del Factor de Necrosis Tumoral; Factor de Necrosis Tumoral alfa

Palabras clave

infection- bacterial/fungal/viral; psoriasis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Antirreumáticos / COVID-19 Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google